Ride Health and COVID-19 Prevention Trials Network (CoVPN) Partner to Provide Transportation for Vaccine Trial Participants
(WorldNews Health)

NEW YORK, Jan. 20, 2021 /PRNewswire/ --�Ride Health, coordinating smarter transportation for every patient need, is partnering with the COVID-19 Prevention Trials Network (CoVPN), a network for large-scale vaccine and therapeutic testing established by the National Institute for Allergy and Infectious Disease (NIAID) at the National Institutes of Health (NIH). CoVPN is the harmonizing entity among the five Operation Warp Speed-backed Phase 3 COVID-19 vaccine efficacy trials. Each study is anticipated to enroll roughly 30,000 people, with a focus on enrolling individuals at risk for exposure to COVID-19. In addition to providing transportation for all vaccine trial participants, CoVPN has...